Expression of Prostaglandin G/H Synthase-1 and -2 Protein in Human Colon Cancer

Cancer Research

Volumn 55, Issue 12, 1995, Pages 2556-2559

  Kargman, Stacia L ^a   O'Neill, Gary P ^a   Vickers, Philip J ^b   Evans, Jilly F ^a   Mancini, Joseph A ^a   Jothy, Serge ^c  

^a MERCK FROSST CENTRE FOR THERAPEUTIC RESEARCH   (Canada)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN G; PROSTAGLANDIN H; PROSTAGLANDIN SYNTHASE; PROSTAGLANDIN SYNTHASE 1; PROSTAGLANDIN SYNTHASE 2; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BREAST CANCER; COLON CANCER; COLON POLYP; CONTROLLED STUDY; GENE EXPRESSION; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; PRECANCER AND CANCER-IN-SITU; PRIORITY JOURNAL;

ADENOMATOUS POLYPS; BREAST; BREAST NEOPLASMS; COLON; COLONIC NEOPLASMS; COMPARATIVE STUDY; FEMALE; GENE EXPRESSION; HUMAN; IMMUNOBLOTTING; INTESTINAL MUCOSA; ISOENZYMES; NEOPLASM STAGING; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASE; REFERENCE VALUES;

EID: 0029008617     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Watkins, W. D., Peterson, M. B., and Fletcher, J. R. (eds.) Prostaglandins in Clinical Practice. New York:Raven, 1989.
2. Dewitt, D. L. Prostaglandin endoperoxide synthase:regulation and enzyme expression. Biochim. Biophys. Acta, 7083:121–134, 1991.
3. Xie, W., Robertson, D. L., and Simmons, D. L. Mitogen-inducible prostaglandin G/H synthase:a new target for nonsteroidal antiinflammatory drugs. Drug Dev. Res., 25:249–265, 1992.
4. Loll, P. J., and Garavito, R. M. The isoforms of cyclooxygenase:structure and function. Expert Opin. Invest. Drugs, 3:1171–1180, 1994.
5. Battistini, B., Botting, R., and Bakhle, Y. S. COX-1 and COX-2:toward the development of more selective NSAIDS. Drug News Perspect., 7:501–512, 1994.
6. Masferrer, J. L., Zweifel, B. S., Manning, P. T., Hauser, S. D., Leahy, K. M., Smith, W. G., Isakson, P. C., and Seibert, K. Selective inhibition of inducible cyclooxygenase 2 in vivo is antiinflammatory and nonulcerogenic. Proc. Natl. Acad. Sci. USA, 91:3228–3232, 1994.
7. O'Neill, G. P., Mancini, J. A., Kargman, S., Yergey, J., Kwan, M. Y., Falgueyrct, J-P., Abramovitz, M., Kennedy, B. P., Ouellet, M., Cromlish, W., Culp, S., Evans, J. F., Ford-Hutchinson, A. W., and Vickers, P. J. Overexpression of human prostaglandin G/H synthase-1 and -2 by recombinant vaccinia virus:inhibition by nonsteroidal anti-inflammatory drugs and biosynthesis of 15-hydroxyeicosatetraenoic acid. Mol. Pharmacol., 45:245–254, 1994.
8. DeWitt, D. L., Meade, E. A., and Smith, W. L. PGH synthase isoenzyme selectivity:the potential for safer nonsteroidal antiinflammatory drugs. Am. J. Med., 95 (Suppl.):40S–44S, 1993.
9. McLemore, T. L., Hubbard, W. C., Litterst, C. L., Liu, M. C., Miller, S., McMahon, N. A., Eggleston, J. C., and Boyd, M. R. Profiles of prostaglandin biosynthesis in normal lung and tumor tissue from lung cancer patients. Cancer Res., 48:3140–3147, 1988.
10. Rigas, B., Goldman, I. S., and Levine, L. Altered eicosanoid levels in human colon cancer. J. Lab. Clin. Med., 722:518–523, 1993.
11. Earnest, D. L., Hixson, L. J., and Alberts, D. S. Piroxicam and other cyclooxygenase inhibitors:potential for cancer chemoprevention. J. Cell. Biochem., 767 (Suppl.); 156–166, 1992.
12. Heath, C. W., Jr., Thun, M. J., Greenberg, E. R., Levin, B., and Marnett, L. J. Nonsteroidal antiinflammatory drugs and human cancer. Cancer (Phila.), 74:2885–2888, 1994.
13. Laemmli, U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (Lond.), 227:680–685, 1970.
14. Towbin, H., Staehelin, T., and Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets:procedure and some applications. Proc. Natl. Acad. Sci. USA, 75:4350–4354, 1979.
15. Freund, J. E. Mathematical Statistics. Englewood Cliffs, NJ:Prentice Hall, 1992.
16. Otto, J. C., DeWitt, D. L. S., and Smith, W. L. N-Glycosylation of prostaglandin endoperoxide synthases-1 and -2 and their orientations in the endoplasmic reticulum. J. Biol. Chem., 268:18234–18242, 1993.
17. Bennett, A., Del Tacca, M., Stamford, I. F., and Zebro, T. Prostaglandins from tumours of human large bowel. Br. J. Cancer, 35:881–884, 1977.
18. Bennett, A., Civier, A., Hensby, C. N., Melhuish, P. B., and Stamford, I. F. Measurement of arachidonate and its metabolites extracted from human normal and malignant gastrointestinal tissues. Gut, 28:315–318, 1987.
19. Eberhart, C. E., Coffey, R. J., Radhika, A., Giardiello, F. M., Ferrenbach, S., and Dubois, R. N. Up-regulation of cyclooxygenase 2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107:1183–1188, 1994.
20. Hoff, T., DeWitt, D., Kaever, V., Resch, K., and Goppelt-Struebe, M. Differentiation-associated expression of prostaglandin G/H synthase in monocytic cells. FEBS Lett., 320:38–42, 1993.
21. Lee, S. H., Soyoola, E., Chanmugam, P., Hart, S., Sun, W., Zhong, H., Liou, S., Simmons, D., and Hwang, D. Selective expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide. J. Biol. Chem., 267:25934–25938, 1992.
22. Ladenheim, J., Garcia, G., Titzer, D., Herzenberg, H., Lavori, P., Edson, R., and Omary, B. Effect of sulindac on sporadic colonic polyps. Gastroenterology, 108:1083–1087, 1995.
23. Futaki, N., Yoshikawa, K., Hamasaka, Y., Arai, I., Higuchi, S., Iizuka, H., and Otomo, S. NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesions. Gen. Pharmacol., 24:105–110, 1993.
24. Futaki, N., Takahashi, S., Yokoyama, M., Arai, I., Higuchi, S., and Otomo, S. NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H syn-thase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins, 47:55–59, 1994.